–– San Diego Research Studies

San Diego is a center for diabetes research!

Want to volunteer for a study?  Contact one of the organizations listed below.
Want your organization listed here? Email us your organization's information.
Need volunteers for a particular study? Email us the details and we'll list it below.
Our email address: sdinsulinpumpers@gmail.com

The following organizations conduct, facilitate, and/or need volunteers for diabetes research:

----------------------------------------------

UCSD Clinical Diabetes Research Group

Do you have Diabetes?

Interested in learning about clinical trials you may qualify for?

Complete our short survey!

Follow this link: https://redcap.link/diabetesresearch

The Clinical Diabetes Research Group at UCSD is conducting several studies on type 1, type 2, and prediabetes. We will contact you with potential opportunitiies as they become available.

Here is a little video we made talking about what we do:

https://youtu.be/e0vy1F-Ck1U

Thank you!

----------------------------------------------

AMCR Institute, Inc.

Has diabetes affected you, or the life of a loved one?

BE PART OF A NEW APPROACH TO DIABETES CARE.

Join a clinical study that can bring life-saving solutions to you and the diabetes community.

You may receive related health care at no cost, and get paid for it!

We have helped thousands of patients over 25 years.

Call 1-877-567-AMCR today or visit myAMCR.com

Karina Rodriguez, BSHCA
Research Recruitment Supervisor

AMCR Institute, Inc.
625 West Citracado Parkway, Suite 112
Escondido, CA  92025

P (760) 466-1520
F (760) 466-1525

krodriguez@amcrinstitute.com
www.amcrinstitute.com

Excellence in clinical research, accelerating access to treatments that change lives.

----------------------------------------------

Diabetes Research Connection

Funding for diabetes research has decreased significantly over the past several years. Of the funding available, 97% goes to established scientists conducting conventional research.
Scientists starting out in diabetes research, also known as early-career scientists, have a difficult time finding money to support their innovative ideas. The Diabetes Research Connection, a local nonprofit organization, created a platform connecting donors directly with early-career scientists, enabling them to perform peer-reviewed, diabetes research designed to prevent and cure type 1 diabetes, minimize its complications and improve the quality of life for those living with the disease.

Join us and influence the future of diabetes research today!

Website: www.DiabetesResearchConnection.org
Phone: 844-484-3372

----------------------------------------------

Prosciento

Prosciento needs Type 1 volunteers for ongoing research studies.

Call (866) 308-7427 for information.

Aditi Sawhney
Recruitment Marketing Specialist
ProSciento, Inc.
855 3rd Avenue, Suite 3340
Chula Vista, CA  91911 U.S.A.
P: +1 (619)-502-7788 ext. 284
Aditi.Sawhney@prosciento.com
www.prosciento.com

----------------------------------------------

TCOYD Research Registry

For information about joining TCOYD's Research Registry, call 1-855-850-3599 (toll free).
Your inquiry does not commit you to joining the program – it only tells us that you are interested in learning more. Then, you can decide if T1-REDEEM is right for you. 

If you join, TCOYD will contact you directly about new studies. 

We're now conducting the following study.

T1-REDEEM Study

TCOYD currently needs participants for a unique project sponsored by the National Institutes of Health as part of a collaboration between the TCOYD Research Registry and a team at the University of California, San Francisco.

Unlike previous studies we have conducted, this one will evaluate a program to help adults with type 1 diabetes be more successful living with and managing their diabetes. Something that people rarely talk about is how tough type 1 diabetes can be and how many people find diabetes to be stressful and a challenge.  So we developed the T1-REDEEM project (Reducing Distress and Enhancing Effective Management).  

T1-REDEEM compares two, proven small group programs to see which one works best for people with type 1 diabetes. Each program begins with a one-day workshop (held on a Saturday in San Diego) and the rest is completed online and by phone.  Both programs are behavioral, meaning that you will not be asked to change or try any new medications or equipment. You  will receive a gift card for your time and there are no costs to you or your insurance. There is no age limit to taking part and we welcome anyone age 19 years or older!

We hope that you will be interested in learning more about this exciting new program! 

Call 1-855-850-3599  to get more information and see if you are eligible. Living with Type 1 diabetes can be tough, and this new program is designed to help reduce the ongoing stresses and strains that most people with diabetes experience. We hope to hear from you so that we can tell you more about T1-REDEEM and answer your questions. 

 –The TCOYD Research Registry Team

----------------------------------------------

Thrivable Research

In 2022, and with the pandemic slowly easing, hundreds of Thrivable members participated in in-person research activities nationwide, earning over $100,000 in incentives, collectively. These research activities helped to advance the future of diabetes care by helping med-tech companies develop new products based on real insights. We look forward to much more in 2023!

With a new year comes a renewed focus from our team at Thrivable. Our goal is to be the #1 company for healthcare companies, primarily in the diabetes space, to come to for any of their research needs. To accomplish this, we are committed to building a happy, healthy and engaged community of panel members (that’s you!) who are just as committed to shaping the future of healthcare treatment in diabetes and other chronic conditions as we are. 

Over the course of the year expect to see the following:

o More opportunities to participate in research studies. Which means more opportunities to earn money.

o A more diverse range of research studies to participate in: from short surveys, to in-person interviews, to new product testing.

o Improved communications, so when the right research opportunity presents itself to you, you know about it and can be sure to participate.

At Thrivable, we are only as strong as the members we have access to within our database. While we work tirelessly to improve your member experience, would you please consider helping us? Here are a few ways you could help:

o Take every opportunity we present to update your profile. The more updated your profile is the higher the likelihood you will match for a research study. 

o Ask your friends and family to sign up and become a Thrivable panel member. We are looking for people of all ages who live with pre-diabetes or diabetes, along with their caregivers. The more individuals we have on file, the more powerful our collective voice will be as we work together to advance healthcare in the diabetes space.

o Rate us 5 stars and share your positive experience with Thrivable on our Facebook page.

We look forward to an amazing year ahead as we work hand-in-hand to be the #1 company for healthcare companies in the diabetes space to come to for any of their research needs.

Adam Zandman
Marketing Director
Adam @ Thrivable <adamz@thrivable.app>

----------------------------------------------

UCSD GRA Study

Purpose - To test the effect a glucagon receptor antagonist (GRA), essentially a glucagon blocker, has on insulin sensitivity and cardiovascular health in people with type 1 diabetes.

Study Drug - REMD-477 35mg in .5mL of normal saline given subcutaneously.  REMD-477 is given here at the clinic once a week for 10-12 weeks.  There is a placebo for this study, so you have 50% chance of getting the study drug and 50% of getting placebo.

Study Length - Approximately 3.5 months.  15-17 total visits to the research clinic.

Main Procedures - Physical exam, vital signs, blood collection, cardiovascular tests, insulin sensitivity test and insulin withdrawal test.  The cardiovascular tests both measure the health of your blood vessels and are called FMD and EndoPAT tests.  The FMD uses an ultrasound to measure an artery in your upper arm and the EndoPAT measures the health of your capillaries in your fingers.  Both tests are non-invasive and take between 15-25 minutes each.  The insulin sensitivity test (also called a clamp) measures your bodies response to different rates of insulin infusion.  The test takes about 8 hours, we'll put in 2 IVs to give you insulin, dextrose and draw your blood.  You'll be in a private room, resting in a regular hospital bed during the testing.  The insulin withdrawal test measures your ketones over 6-8 hours after we suspend your insulin.  We'll put in 1 IV to monitor blood sugars and ketones and You'll be in a private room, resting in a regular hospital bed during the testing.

Payment - $50 for Screening, $300 for Insulin Sensitivity visit 1, $300 for Cardiovascular visit 1 and dose 1, $50 for weekly dosing visits, $200 for Cardiovascular visit 2, $300 for Insulin Sensitivity visit 2, $300 for Insulin Withdrawal visit 1 and $50 for the final safety follow-up visit ( up to $1800).

Contact:

Erin Giovannetti MSN, FNP-C

Office- (858) 246-2169

Cell- (949) 698- 2169

Altman Clinical and Translational Research

Institute (ACTRI)

9452 Medical Center Drive

La Jolla, CA 92037

L1-W-513

----------------------------------------------